omniture
SPECIALISED THERAPEUTICS AUSTRALIA PTY LTD

Latest News

New Early Breast Cancer Drug Now Approved in Malaysia

SINGAPORE, July 16, 2020 /PRNewswire/ -- A NEW breast cancer drug shown to significantly reduce the...

2020-07-17 06:16 1376

New Small Cell Lung Cancer Drug Accepted for TGA Evaluation Under Project Orbis

Key Highlights * TGA has granted provisional designation for new drug Lurbinectedin based on enc...

2020-06-03 14:30 636

New Early Breast Cancer Drug Available Now In Singapore

* NERLYNX® (neratinib) now commercially available in Singapore for HER2+ breast cancer patients f...

2020-04-23 12:33 1146

Specialised Therapeutics Signs Exclusive Deal for New Haematology Drug

SINGAPORE, Dec. 18, 2019 /PRNewswire/ -- Independent pharmaceutical company Specialised Therapeutic...

2019-12-18 22:00 1004

New Early Breast Cancer Drug Approved by Singapore Health Sciences Authority

* NERLYNX® (neratinib) now approved in Singapore for HER2+ breast cancer patients following adjuv...

2019-12-03 05:30 545

STA To Market Sarcoma Drug In Australia, New Zealand And SE Asia Following License Deal

SINGAPORE and MELBOURNE, Australia, Oct. 14, 2019 /PRNewswire/ -- Independent pharmaceutical compan...

2019-10-14 14:00 511

New Drug for Diabetes-Induced Vision Loss TGA-Approved for Australian Patients

MELBOURNE, Australia and ATLANTA, Aug. 5, 2019 /PRNewswire/ -- Australian patients with diabetes-in...

2019-08-05 20:00 1477

Aadi Bioscience Breakthrough Therapy nab-Sirolimus (ABI-009) Preliminary Data Released from the AMPECT Registration Trial in Advanced PEComa

Highlights: * 42% investigator-assessed ORR achieved in patients with advanced PEComa – a rare s...

2019-06-04 06:39 2041

New Early Breast Cancer Drug to Reduce Risk of Recurrence or Death Approved for Australian Women(1)

* NERLYNX® (neratinib) now approved by the Therapeutic Goods Administration for Australian women2...

2019-03-18 20:45 473

New Early Breast Cancer Drug To Be Made Available In Singapore Via Special Access Program

SINGAPORE, Feb. 18, 2019 /PRNewswire/ -- A NEW breast cancer drug shown to significantly reduce the...

2019-02-18 07:25 1165

World-first Approval For Multiple Myeloma Drug APLIDIN(R)

Australia's Therapeutic Goods Administration approves APLIDIN (plitidepsin) for relapsed/refractory...

2018-12-11 15:10 417

New Early- Breast Cancer Drug to be Made Available in Australia, New Zealand and South East Asia Following License Deal

SINGAPORE and MELBOURNE, Australia, Nov. 22, 2017 /PRNewswire/ -- A NEW breast cancer drug shown to...

2017-11-22 22:30 723

Specialised Therapeutics Asia to License Promising Anti-Cancer Compound Lurbinectedin (PM1183) for South East Asia, Australia and New Zealand

Lurbinectedin (PM1183) is a novel anti-cancer drug in final stage trials for platinum-resistant o...

2017-05-18 00:23 1700

Novel Multiple Myeloma Drug Aplidin(R) Shows Positive Results in Pivotal Phase 3 Study

SINGAPORE, MADRID and MELBOURNE, Australia, March 31, 2016 /PRNewswire/ -- International biopharmace...

2016-03-31 16:32 1991

Specialized Therapeutics Grants Sublicense for Anti-Emetic Products to Mundipharma for Australia and New Zealand

MELBOURNE, Australia, March 7, 2016 /PRNewswire/ -- Specialized Therapeutics Pty Ltd and Mundipharma...

2016-03-07 22:00 1830